查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2025-2029年全球注射笔市场
市场调查报告书
商品编码
1859840

2025-2029年全球注射笔市场

Global Injection Pen Market 2025-2029
出版日期: | 出版商: TechNavio | 英文 223 Pages | 订单完成后即时交付

价格

预计 2024 年至 2029 年间，注射笔市场规模将达 286.166 亿美元，预测期内复合年增长率为 8.4%。

本报告对注射笔市场进行了全面分析，包括市场规模和预测、趋势、成长驱动因素、挑战以及涵盖约 25 家供应商的供应商分析。

该报告对当前市场状况、最新趋势和驱动因素以及整体市场环境进行了最新分析。市场成长的驱动因素包括慢性病盛行率上升、糖尿病患者人数增加、注射疗法日益普及。

市场覆盖范围
基准年 2025
年末 2029
预测期 2025-2029
成长势头 加速度
同比 7.8%
复合年增长率 8.4%
增量 286.166亿美元

本研究采用客观的方法，结合一手和二手讯息，并参考了业界主要参与者的意见。报告分析了主要企业，并提供了全面的市场规模数据、区域細項分析和供应商格局。报告包含历史数据和预测数据。

报告指出，胰岛素笔需求的显着成长是未来几年推动注射笔市场成长的关键因素之一。此外，市场参与者不断推出新的注射笔产品，以及越来越多的新产品获得商业批准，也将显着刺激市场需求。

目录

第一章执行摘要

  • 市场概览

第二章 Technavio 分析

  • 价格、生命週期、顾客购买篮、采用率和购买标准分析
  • 投入与差异化因素的重要性
  • 混淆来源
  • 驱动因素和挑战的影响

第三章 市场情势

  • 市场生态系统
  • 市场特征
  • 价值链分析

第四章 市场规模

  • 市场定义
  • 市场区隔分析
  • 2024年市场规模
  • 2024-2029年市场展望

第五章 市场规模表现

  • 2019-2023年全球注射笔市场
  • 2019-2023年产品细分市场分析
  • 类型细分市场分析 2019-2023
  • 2019-2023年最终用户细分市场分析
  • 2019-2023年区域细分市场分析
  • 2019-2023年国家细分市场分析

第六章 定性分析

  • 人工智慧的影响：全球注射笔市场

第七章五力分析

  • 五力摘要
  • 买方的议价能力
  • 供应商的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争威胁
  • 市场状况

第八章 按产品进行市场细分

  • 市场区隔
  • 比较：按产品
  • 生长激素：市场规模及预测（2024-2029年）
  • 糖尿病：市场规模及预测（2024-2029 年）
  • 生育力：市场规模及预测（2024-2029 年）
  • 骨质疏鬆症：市场规模及预测（2024-2029年）
  • 其他：市场规模及2024-2029年预测
  • 按产品分類的市场机会

第九章 按类型分類的市场细分

  • 市场区隔
  • 比较：按类型
  • 一次性注射笔：市场规模及预测（2024-2029年）
  • 可重复使用注射笔：市场规模及预测（2024-2029年）
  • 按类型分類的市场机会

第十章 按最终用户进行市场细分

  • 市场区隔
  • 比较：按最终用户
  • 医院：市场规模及预测（2024-2029 年）
  • 居家照护：市场规模及预测（2024-2029年）
  • ASC市场：市场规模及2024-2029年预测
  • 按最终用户分類的市场机会

第十一章 客户情况

  • 客户概览

第十二章 区域情势

  • 区域细分
  • 区域比较
  • 北美：市场规模及预测（2024-2029 年）
  • 欧洲：市场规模及2024-2029年预测
  • 亚洲：市场规模及预测（2024-2029年）
  • 世界其他地区：市场规模及预测（2024-2029年）
  • 美国：市场规模及预测（2024-2029年）
  • 加拿大：市场规模及预测（2024-2029年）
  • 英国：市场规模及预测（2024-2029年）
  • 巴西：市场规模及预测（2024-2029年）
  • 德国：市场规模及2024-2029年预测
  • 中国：市场规模及预测（2024-2029年）
  • 法国：市场规模及2024-2029年预测
  • 印度：市场规模及预测（2024-2029 年）
  • 日本：市场规模及2024-2029年预测
  • 义大利：市场规模及2024-2029年预测
  • 各区域的市场机会

第十三章 驱动因素、挑战、机会与限制因素

  • 市场驱动因素
  • 市场挑战
  • 驱动因素和挑战的影响
  • 市场机会与限制因素

第十四章 竞争格局

  • 概述
  • 竞争格局
  • 令人困惑的局面
  • 产业风险

第十五章 竞争分析

  • 公司简介
  • 公司排名
  • 公司市场定位
  • AstraZeneca Plc
  • Becton Dickinson and Co.
  • Biocon Ltd.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Gerresheimer AG
  • GlaxoSmithKline Plc
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk AS
  • Owen Mumford Ltd.
  • Pfizer Inc.
  • Sanofi SA
  • Viatris Inc.
  • Ypsomed Holding AG

第十六章附录

Product Code: IRTNTR71195

The injection pen market is forecasted to grow by USD 28,616.6 mn during 2024-2029, accelerating at a CAGR of 8.4% during the forecast period. The report on the injection pen market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic diseases, growing prevalence of diabetes cases, and growing popularity of injectable therapies.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20257.8%
CAGR8.4%
Incremental Value$28,616.6 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's injection pen market is segmented as below:

By Product

    • Growth hormone
    • Diabetes
    • Fertility
    • Osteoporosis
    • Others

By Type

    • Disposable injection pen
    • Reusable injection pen

By End-user

    • Hospitals
    • Homecare settings
    • ASCs

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the significant rise in demand for insulin pens as one of the prime reasons driving the injection pen market growth during the next few years. Also, increasing injection pen product launches by market companies and rise in commercial approvals of new products will lead to sizable demand in the market.

The report on the injection pen market covers the following areas:

    • Injection Pen Market sizing
    • Injection Pen Market forecast
    • Injection Pen Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading injection pen market vendors that include AstraZeneca Plc, Becton Dickinson and Co., Biocon Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gan and Lee Pharmaceuticals Co. Ltd., Gerresheimer AG, GlaxoSmithKline Plc, Harro Hofliger GmbH, Haselmeier GmbH, Jiangsu Delfu medical device Co. Ltd., Merck KGaA, Novartis AG, Novo Nordisk AS, Owen Mumford Ltd., Pfizer Inc., Sanofi SA, Solteam Electronics Co LTD., Viatris Inc., and Ypsomed Holding AG. Also, the injection pen market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Product
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Injection Pen Market 2019 - 2023
    • Historic Market Size - Data Table on Global Injection Pen Market 2019 - 2023 ($ million)
  • 5.2 Product segment analysis 2019 - 2023
    • Historic Market Size - Product Segment 2019 - 2023 ($ million)
  • 5.3 Type segment analysis 2019 - 2023
    • Historic Market Size - Type Segment 2019 - 2023 ($ million)
  • 5.4 End-user segment analysis 2019 - 2023
    • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 The AI impact on Global Injection Pen Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

  • 8.1 Market segments
    • Chart on Product - Market share 2024-2029 (%)
    • Data Table on Product - Market share 2024-2029 (%)
  • 8.2 Comparison by Product
    • Chart on Comparison by Product
    • Data Table on Comparison by Product
  • 8.3 Growth hormone - Market size and forecast 2024-2029
    • Chart on Growth hormone - Market size and forecast 2024-2029 ($ million)
    • Data Table on Growth hormone - Market size and forecast 2024-2029 ($ million)
    • Chart on Growth hormone - Year-over-year growth 2024-2029 (%)
    • Data Table on Growth hormone - Year-over-year growth 2024-2029 (%)
  • 8.4 Diabetes - Market size and forecast 2024-2029
    • Chart on Diabetes - Market size and forecast 2024-2029 ($ million)
    • Data Table on Diabetes - Market size and forecast 2024-2029 ($ million)
    • Chart on Diabetes - Year-over-year growth 2024-2029 (%)
    • Data Table on Diabetes - Year-over-year growth 2024-2029 (%)
  • 8.5 Fertility - Market size and forecast 2024-2029
    • Chart on Fertility - Market size and forecast 2024-2029 ($ million)
    • Data Table on Fertility - Market size and forecast 2024-2029 ($ million)
    • Chart on Fertility - Year-over-year growth 2024-2029 (%)
    • Data Table on Fertility - Year-over-year growth 2024-2029 (%)
  • 8.6 Osteoporosis - Market size and forecast 2024-2029
    • Chart on Osteoporosis - Market size and forecast 2024-2029 ($ million)
    • Data Table on Osteoporosis - Market size and forecast 2024-2029 ($ million)
    • Chart on Osteoporosis - Year-over-year growth 2024-2029 (%)
    • Data Table on Osteoporosis - Year-over-year growth 2024-2029 (%)
  • 8.7 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 8.8 Market opportunity by Product
    • Market opportunity by Product ($ million)
    • Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by Type

  • 9.1 Market segments
    • Chart on Type - Market share 2024-2029 (%)
    • Data Table on Type - Market share 2024-2029 (%)
  • 9.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 9.3 Disposable injection pen - Market size and forecast 2024-2029
    • Chart on Disposable injection pen - Market size and forecast 2024-2029 ($ million)
    • Data Table on Disposable injection pen - Market size and forecast 2024-2029 ($ million)
    • Chart on Disposable injection pen - Year-over-year growth 2024-2029 (%)
    • Data Table on Disposable injection pen - Year-over-year growth 2024-2029 (%)
  • 9.4 Reusable injection pen - Market size and forecast 2024-2029
    • Chart on Reusable injection pen - Market size and forecast 2024-2029 ($ million)
    • Data Table on Reusable injection pen - Market size and forecast 2024-2029 ($ million)
    • Chart on Reusable injection pen - Year-over-year growth 2024-2029 (%)
    • Data Table on Reusable injection pen - Year-over-year growth 2024-2029 (%)
  • 9.5 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

10 Market Segmentation by End-user

  • 10.1 Market segments
    • Chart on End-user - Market share 2024-2029 (%)
    • Data Table on End-user - Market share 2024-2029 (%)
  • 10.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 10.3 Hospitals - Market size and forecast 2024-2029
    • Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
    • Chart on Hospitals - Year-over-year growth 2024-2029 (%)
    • Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
  • 10.4 Homecare settings - Market size and forecast 2024-2029
    • Chart on Homecare settings - Market size and forecast 2024-2029 ($ million)
    • Data Table on Homecare settings - Market size and forecast 2024-2029 ($ million)
    • Chart on Homecare settings - Year-over-year growth 2024-2029 (%)
    • Data Table on Homecare settings - Year-over-year growth 2024-2029 (%)
  • 10.5 ASCs - Market size and forecast 2024-2029
    • Chart on ASCs - Market size and forecast 2024-2029 ($ million)
    • Data Table on ASCs - Market size and forecast 2024-2029 ($ million)
    • Chart on ASCs - Year-over-year growth 2024-2029 (%)
    • Data Table on ASCs - Year-over-year growth 2024-2029 (%)
  • 10.6 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.9 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.10 Brazil - Market size and forecast 2024-2029
    • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
    • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
    • Chart on Brazil - Year-over-year growth 2024-2029 (%)
    • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • 12.11 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.12 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.13 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.14 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.15 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.16 Italy - Market size and forecast 2024-2029
    • Chart on Italy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
    • Chart on Italy - Year-over-year growth 2024-2029 (%)
    • Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 AstraZeneca Plc
    • AstraZeneca Plc - Overview
    • AstraZeneca Plc - Product / Service
    • AstraZeneca Plc - Key news
    • AstraZeneca Plc - Key offerings
    • SWOT
  • 15.5 Becton Dickinson and Co.
    • Becton Dickinson and Co. - Overview
    • Becton Dickinson and Co. - Business segments
    • Becton Dickinson and Co. - Key news
    • Becton Dickinson and Co. - Key offerings
    • Becton Dickinson and Co. - Segment focus
    • SWOT
  • 15.6 Biocon Ltd.
    • Biocon Ltd. - Overview
    • Biocon Ltd. - Business segments
    • Biocon Ltd. - Key offerings
    • Biocon Ltd. - Segment focus
    • SWOT
  • 15.7 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key offerings
    • SWOT
  • 15.8 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 15.9 Gerresheimer AG
    • Gerresheimer AG - Overview
    • Gerresheimer AG - Business segments
    • Gerresheimer AG - Key news
    • Gerresheimer AG - Key offerings
    • Gerresheimer AG - Segment focus
    • SWOT
  • 15.10 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
    • SWOT
  • 15.11 Merck KGaA
    • Merck KGaA - Overview
    • Merck KGaA - Business segments
    • Merck KGaA - Key news
    • Merck KGaA - Key offerings
    • Merck KGaA - Segment focus
    • SWOT
  • 15.12 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT
  • 15.13 Novo Nordisk AS
    • Novo Nordisk AS - Overview
    • Novo Nordisk AS - Business segments
    • Novo Nordisk AS - Key offerings
    • Novo Nordisk AS - Segment focus
    • SWOT
  • 15.14 Owen Mumford Ltd.
    • Owen Mumford Ltd. - Overview
    • Owen Mumford Ltd. - Product / Service
    • Owen Mumford Ltd. - Key offerings
    • SWOT
  • 15.15 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 15.16 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
    • SWOT
  • 15.17 Viatris Inc.
    • Viatris Inc. - Overview
    • Viatris Inc. - Business segments
    • Viatris Inc. - Key news
    • Viatris Inc. - Key offerings
    • Viatris Inc. - Segment focus
    • SWOT
  • 15.18 Ypsomed Holding AG
    • Ypsomed Holding AG - Overview
    • Ypsomed Holding AG - Business segments
    • Ypsomed Holding AG - Key offerings
    • Ypsomed Holding AG - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits7: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global Injection Pen Market 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Product Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Type Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on Product - Market share 2024-2029 (%)
  • Exhibits39: Data Table on Product - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by Product
  • Exhibits41: Data Table on Comparison by Product
  • Exhibits42: Chart on Growth hormone - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on Growth hormone - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on Growth hormone - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on Growth hormone - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on Diabetes - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on Diabetes - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on Diabetes - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on Diabetes - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Chart on Fertility - Market size and forecast 2024-2029 ($ million)
  • Exhibits51: Data Table on Fertility - Market size and forecast 2024-2029 ($ million)
  • Exhibits52: Chart on Fertility - Year-over-year growth 2024-2029 (%)
  • Exhibits53: Data Table on Fertility - Year-over-year growth 2024-2029 (%)
  • Exhibits54: Chart on Osteoporosis - Market size and forecast 2024-2029 ($ million)
  • Exhibits55: Data Table on Osteoporosis - Market size and forecast 2024-2029 ($ million)
  • Exhibits56: Chart on Osteoporosis - Year-over-year growth 2024-2029 (%)
  • Exhibits57: Data Table on Osteoporosis - Year-over-year growth 2024-2029 (%)
  • Exhibits58: Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits59: Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits60: Chart on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits61: Data Table on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits62: Market opportunity by Product ($ million)
  • Exhibits63: Data Table on Market opportunity by Product ($ million)
  • Exhibits64: Chart on Type - Market share 2024-2029 (%)
  • Exhibits65: Data Table on Type - Market share 2024-2029 (%)
  • Exhibits66: Chart on Comparison by Type
  • Exhibits67: Data Table on Comparison by Type
  • Exhibits68: Chart on Disposable injection pen - Market size and forecast 2024-2029 ($ million)
  • Exhibits69: Data Table on Disposable injection pen - Market size and forecast 2024-2029 ($ million)
  • Exhibits70: Chart on Disposable injection pen - Year-over-year growth 2024-2029 (%)
  • Exhibits71: Data Table on Disposable injection pen - Year-over-year growth 2024-2029 (%)
  • Exhibits72: Chart on Reusable injection pen - Market size and forecast 2024-2029 ($ million)
  • Exhibits73: Data Table on Reusable injection pen - Market size and forecast 2024-2029 ($ million)
  • Exhibits74: Chart on Reusable injection pen - Year-over-year growth 2024-2029 (%)
  • Exhibits75: Data Table on Reusable injection pen - Year-over-year growth 2024-2029 (%)
  • Exhibits76: Market opportunity by Type ($ million)
  • Exhibits77: Data Table on Market opportunity by Type ($ million)
  • Exhibits78: Chart on End-user - Market share 2024-2029 (%)
  • Exhibits79: Data Table on End-user - Market share 2024-2029 (%)
  • Exhibits80: Chart on Comparison by End-user
  • Exhibits81: Data Table on Comparison by End-user
  • Exhibits82: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Exhibits83: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Exhibits84: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
  • Exhibits85: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
  • Exhibits86: Chart on Homecare settings - Market size and forecast 2024-2029 ($ million)
  • Exhibits87: Data Table on Homecare settings - Market size and forecast 2024-2029 ($ million)
  • Exhibits88: Chart on Homecare settings - Year-over-year growth 2024-2029 (%)
  • Exhibits89: Data Table on Homecare settings - Year-over-year growth 2024-2029 (%)
  • Exhibits90: Chart on ASCs - Market size and forecast 2024-2029 ($ million)
  • Exhibits91: Data Table on ASCs - Market size and forecast 2024-2029 ($ million)
  • Exhibits92: Chart on ASCs - Year-over-year growth 2024-2029 (%)
  • Exhibits93: Data Table on ASCs - Year-over-year growth 2024-2029 (%)
  • Exhibits94: Market opportunity by End-user ($ million)
  • Exhibits95: Data Table on Market opportunity by End-user ($ million)
  • Exhibits96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits97: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits98: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits99: Chart on Geographic comparison
  • Exhibits100: Data Table on Geographic comparison
  • Exhibits101: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits102: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits103: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits104: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits105: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits106: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits107: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits108: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits109: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits150: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits151: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits152: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits153: Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits154: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits155: Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits156: Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits157: Market opportunity By Geographical Landscape ($ million)
  • Exhibits158: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits159: Impact of drivers and challenges in 2024 and 2029
  • Exhibits160: Overview on criticality of inputs and factors of differentiation
  • Exhibits161: Overview on factors of disruption
  • Exhibits162: Impact of key risks on business
  • Exhibits163: Companies covered
  • Exhibits164: Company ranking index
  • Exhibits165: Matrix on companies position and classification
  • Exhibits166: AstraZeneca Plc - Overview
  • Exhibits167: AstraZeneca Plc - Product / Service
  • Exhibits168: AstraZeneca Plc - Key news
  • Exhibits169: AstraZeneca Plc - Key offerings
  • Exhibits170: SWOT
  • Exhibits171: Becton Dickinson and Co. - Overview
  • Exhibits172: Becton Dickinson and Co. - Business segments
  • Exhibits173: Becton Dickinson and Co. - Key news
  • Exhibits174: Becton Dickinson and Co. - Key offerings
  • Exhibits175: Becton Dickinson and Co. - Segment focus
  • Exhibits176: SWOT
  • Exhibits177: Biocon Ltd. - Overview
  • Exhibits178: Biocon Ltd. - Business segments
  • Exhibits179: Biocon Ltd. - Key offerings
  • Exhibits180: Biocon Ltd. - Segment focus
  • Exhibits181: SWOT
  • Exhibits182: Eli Lilly and Co. - Overview
  • Exhibits183: Eli Lilly and Co. - Product / Service
  • Exhibits184: Eli Lilly and Co. - Key offerings
  • Exhibits185: SWOT
  • Exhibits186: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits187: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits188: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits189: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits190: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits191: SWOT
  • Exhibits192: Gerresheimer AG - Overview
  • Exhibits193: Gerresheimer AG - Business segments
  • Exhibits194: Gerresheimer AG - Key news
  • Exhibits195: Gerresheimer AG - Key offerings
  • Exhibits196: Gerresheimer AG - Segment focus
  • Exhibits197: SWOT
  • Exhibits198: GlaxoSmithKline Plc - Overview
  • Exhibits199: GlaxoSmithKline Plc - Business segments
  • Exhibits200: GlaxoSmithKline Plc - Key news
  • Exhibits201: GlaxoSmithKline Plc - Key offerings
  • Exhibits202: GlaxoSmithKline Plc - Segment focus
  • Exhibits203: SWOT
  • Exhibits204: Merck KGaA - Overview
  • Exhibits205: Merck KGaA - Business segments
  • Exhibits206: Merck KGaA - Key news
  • Exhibits207: Merck KGaA - Key offerings
  • Exhibits208: Merck KGaA - Segment focus
  • Exhibits209: SWOT
  • Exhibits210: Novartis AG - Overview
  • Exhibits211: Novartis AG - Business segments
  • Exhibits212: Novartis AG - Key news
  • Exhibits213: Novartis AG - Key offerings
  • Exhibits214: Novartis AG - Segment focus
  • Exhibits215: SWOT
  • Exhibits216: Novo Nordisk AS - Overview
  • Exhibits217: Novo Nordisk AS - Business segments
  • Exhibits218: Novo Nordisk AS - Key offerings
  • Exhibits219: Novo Nordisk AS - Segment focus
  • Exhibits220: SWOT
  • Exhibits221: Owen Mumford Ltd. - Overview
  • Exhibits222: Owen Mumford Ltd. - Product / Service
  • Exhibits223: Owen Mumford Ltd. - Key offerings
  • Exhibits224: SWOT
  • Exhibits225: Pfizer Inc. - Overview
  • Exhibits226: Pfizer Inc. - Product / Service
  • Exhibits227: Pfizer Inc. - Key news
  • Exhibits228: Pfizer Inc. - Key offerings
  • Exhibits229: SWOT
  • Exhibits230: Sanofi SA - Overview
  • Exhibits231: Sanofi SA - Business segments
  • Exhibits232: Sanofi SA - Key news
  • Exhibits233: Sanofi SA - Key offerings
  • Exhibits234: Sanofi SA - Segment focus
  • Exhibits235: SWOT
  • Exhibits236: Viatris Inc. - Overview
  • Exhibits237: Viatris Inc. - Business segments
  • Exhibits238: Viatris Inc. - Key news
  • Exhibits239: Viatris Inc. - Key offerings
  • Exhibits240: Viatris Inc. - Segment focus
  • Exhibits241: SWOT
  • Exhibits242: Ypsomed Holding AG - Overview
  • Exhibits243: Ypsomed Holding AG - Business segments
  • Exhibits244: Ypsomed Holding AG - Key offerings
  • Exhibits245: Ypsomed Holding AG - Segment focus
  • Exhibits246: SWOT
  • Exhibits247: Inclusions checklist
  • Exhibits248: Exclusions checklist
  • Exhibits249: Currency conversion rates for US$
  • Exhibits250: Research methodology
  • Exhibits251: Information sources
  • Exhibits252: Data validation
  • Exhibits253: Validation techniques employed for market sizing
  • Exhibits254: Data synthesis
  • Exhibits255: 360 degree market analysis
  • Exhibits256: List of abbreviations